Cato T Laurencin is Director of MIMEDX GROUP, INC.. Currently has a direct ownership of 153,314 shares of MDXG, which is worth approximately $1.4 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 23,190 shares (Common Stock) at a price of $7.26 per share, resulting in proceeds of $168,359. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K
0% 3M change
17.82% 12M change
Total Value Held $1.4 Million

CATO T LAURENCIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
$168,359 $7.26 p/Share
23,190 Added 13.14%
153,314 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
$175,002 $4.95 p/Share
35,354 Added 21.36%
130,124 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
$174,996 $3.96 p/Share
44,191 Added 31.8%
94,770 Common Stock
May 27 2021
BUY
Grant, award, or other acquisition
$174,995 $10.26 p/Share
17,056 Added 25.22%
50,579 Common Stock
Dec 16 2020
BUY
Grant, award, or other acquisition
$262,485 $7.83 p/Share
33,523 Added 50.0%
33,523 Common Stock

Also insider at

ALKS
Alkermes plc. Healthcare
CTL

Cato T Laurencin

Director
Dublin,

Track Institutional and Insider Activities on MDXG

Follow MIMEDX GROUP, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDXG shares.

Notify only if

Insider Trading

Get notified when an Mimedx Group, Inc. insider buys or sells MDXG shares.

Notify only if

News

Receive news related to MIMEDX GROUP, INC.

Track Activities on MDXG